The Prevention of Hypotension After Epidural Analgesia After Major Surgery
Primary Purpose
Hypotension, Pain
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Ropivacaine
Epinephrine
Sponsored by
About this trial
This is an interventional basic science trial for Hypotension focused on measuring Epidural Analgesia
Eligibility Criteria
Inclusion Criteria:
- undergoing epidural analgesia to treat perioperative pain associated with major surgery
- undergoing major thoracic surgery
- undergoing major abdominal surgery
- undergoing major orthopaedic surgery
Exclusion Criteria:
- sepsis
- acute trauma
- coagulopathy
- preoperative hemodynamic instability
- symptomatic coronary artery disease
- patients from the ICU whose tracheas were intubated for any cause
- allergies to medications in the protocol
- primary or secondary block failure
Sites / Locations
- UF Health
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Placebo Comparator
Active Comparator
Active Comparator
Arm Label
Ropivacaine only Control group
Ropivacaine + 2 mcg/mL epinephrine
Ropivacaine + 5 mcg/mL epinephrine
Arm Description
The participants in this group will receive standard anesthesia, epidural analgesia with 0.2% ropivacaine with no epinephrine added during the procedure.
The participants in this group will receive standard anesthesia (Ropivacaine 0.2%) with the addition of 2mcg/mL of epinephrine during the procedure.
The participants in this group will receive standard anesthesia (Ropivacaine 0.2%) with the addition of 5mcg/mL of epinephrine during the procedure.
Outcomes
Primary Outcome Measures
Changes between the 3 groups assessed by blood pressure measurement
Hypotension will be assessed by systolic blood pressure (SBP) > 20% below the baseline preoperative measurements and acquired before the epidural or any sedation has been administered and the intra-operative period
Secondary Outcome Measures
Changes between the 3 groups assessed by the spread of local anesthetic (block) effect
Spread of local anesthetic (block) effect as tested by sensitivity to cold recorded every hour postoperatively and every 8 hours for the subsequent 72 hours after discharge from the PACU.
Changes between the 3 groups assessed by ambulation after surgery
Ambulation on post-op day 1, post-op day 2 and post-op day 3, will be recorded by distance ambulated per 24-hour period.
Changes between the 3 groups assessed by opioid usage
Opioid usage data will be recorded and converted to morphine equivalents and averaged for day 0, and post-op days 1, 2, and 3 per group.
Changes between the 3 groups assessed by opioid-related side effects
Side effects such as pruritus, nausea/vomiting, and respiratory depression (defined as respiratory rate less than 10 breaths per minute of oxygen saturation more than 7 points lower that the patients preoperative value on room air) will be recorded.
Changes between the 3 groups assessed by fluid balance
24 hour intake and output for the first 72 hours to assess fluid balance
Changes between the 3 groups assessed by length of hospitalization
Length of hospitalization
Changes between the 3 groups assessed by amount of days before return to oral intake status
Return to oral intake status
Full Information
NCT ID
NCT02722746
First Posted
March 23, 2016
Last Updated
February 17, 2020
Sponsor
University of Florida
Collaborators
I. Heermann Anesthesia Foundation
1. Study Identification
Unique Protocol Identification Number
NCT02722746
Brief Title
The Prevention of Hypotension After Epidural Analgesia After Major Surgery
Official Title
The Prevention of Hypotension After Epidural Analgesia After Major Surgery by Adding Epinephrine to Infusions to Counteract Sympathectomy: a Double- Blind, Controlled, Randomized, Prospective Dose-finding Study
Study Type
Interventional
2. Study Status
Record Verification Date
February 2020
Overall Recruitment Status
Completed
Study Start Date
November 15, 2016 (Actual)
Primary Completion Date
October 4, 2017 (Actual)
Study Completion Date
September 14, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Florida
Collaborators
I. Heermann Anesthesia Foundation
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Epidural analgesia via continuous epidurally infused local anesthetic agent (LA) is widely and very successfully used routinely for perioperative pain control in patients undergoing major orthopedic and abdominal surgery since 1928. The choice currently depends on the preference of the APS physician in charge of the case. A frequent unwanted side effect of epidural block is hypotension due to the epidurally injected LA blocking the sympathetic nerves and thus the patient's response to hypotension, which is usually due to hypovolemia and/or an unopposed parasympathetic (via the vagus nerve) nervous system. The purpose of this research study is to see if adding epinephrine, to the epidural anesthetic will decrease possible side effects, such as low blood pressure, and lead to a better effect of the epidural anesthetic.
Detailed Description
Participants undergoing epidural analgesia to treat perioperative pain associated with major surgery will be approached for their willingness to participate in the study. Participants undergoing major thoracic, abdominal, or orthopaedic surgery for whom thoracic or lumbar epidural block would be indicated and planned for intraoperative and postoperative analgesia as per the University of Florida Acute Pain Service (APS) usual and routine practice will be included in this study.
All participants will receive a standardized continuous epidural block at the appropriate level for the planned surgery by the APS physicians in the block room that day. For the standardized continuous epidural block, placement will be confirmed with loss of resistance technique (LORA), wave form analysis or nerve stimulation.
Participants will be randomly allocated by computer-generated randomization to one of four groups. This will be a quintuple blinded prospective study. The anesthesiologist managing the intraoperative anesthesia, the anesthesiologists (APS) placing the blocks and following the participants on the floors, the research nurse taking the measurement, the surgeons, nor the participants will be aware of what combination of drugs are used for the epidural block infusion.
The three groups will consist of:
Group A (Ropivacaine 0.2% infusion; Control group)
Group B (Ropivacaine 0.2% + 2 mcg/mL epinephrine)
Group C (Ropivacaine 0.2% + 5 mcg/mL epinephrine)
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypotension, Pain
Keywords
Epidural Analgesia
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
66 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Ropivacaine only Control group
Arm Type
Placebo Comparator
Arm Description
The participants in this group will receive standard anesthesia, epidural analgesia with 0.2% ropivacaine with no epinephrine added during the procedure.
Arm Title
Ropivacaine + 2 mcg/mL epinephrine
Arm Type
Active Comparator
Arm Description
The participants in this group will receive standard anesthesia (Ropivacaine 0.2%) with the addition of 2mcg/mL of epinephrine during the procedure.
Arm Title
Ropivacaine + 5 mcg/mL epinephrine
Arm Type
Active Comparator
Arm Description
The participants in this group will receive standard anesthesia (Ropivacaine 0.2%) with the addition of 5mcg/mL of epinephrine during the procedure.
Intervention Type
Drug
Intervention Name(s)
Ropivacaine
Other Intervention Name(s)
Naropin
Intervention Description
Epidural block infusion with Ropivacaine 0.2% will be provided as the anesthesia per standard of care during the procedure.
Intervention Type
Drug
Intervention Name(s)
Epinephrine
Other Intervention Name(s)
Adrenalin
Intervention Description
Participants will receive epinephrine in their epidural block infusion during the procedure. The amount of epinephrine provided during the procedure will be based on the group assignment.
Primary Outcome Measure Information:
Title
Changes between the 3 groups assessed by blood pressure measurement
Description
Hypotension will be assessed by systolic blood pressure (SBP) > 20% below the baseline preoperative measurements and acquired before the epidural or any sedation has been administered and the intra-operative period
Time Frame
Change from baseline to end of the intra-operative period
Secondary Outcome Measure Information:
Title
Changes between the 3 groups assessed by the spread of local anesthetic (block) effect
Description
Spread of local anesthetic (block) effect as tested by sensitivity to cold recorded every hour postoperatively and every 8 hours for the subsequent 72 hours after discharge from the PACU.
Time Frame
Change from baseline to 72 hours after discharge from the post anesthesia care unit (PACU)
Title
Changes between the 3 groups assessed by ambulation after surgery
Description
Ambulation on post-op day 1, post-op day 2 and post-op day 3, will be recorded by distance ambulated per 24-hour period.
Time Frame
From post-operative (post-op) day 1 to post-op day 3
Title
Changes between the 3 groups assessed by opioid usage
Description
Opioid usage data will be recorded and converted to morphine equivalents and averaged for day 0, and post-op days 1, 2, and 3 per group.
Time Frame
From day of surgery (0) to post-op day 3
Title
Changes between the 3 groups assessed by opioid-related side effects
Description
Side effects such as pruritus, nausea/vomiting, and respiratory depression (defined as respiratory rate less than 10 breaths per minute of oxygen saturation more than 7 points lower that the patients preoperative value on room air) will be recorded.
Time Frame
From day of surgery (0) to post-op day 3
Title
Changes between the 3 groups assessed by fluid balance
Description
24 hour intake and output for the first 72 hours to assess fluid balance
Time Frame
From post-op day 1 to post-op day 3
Title
Changes between the 3 groups assessed by length of hospitalization
Description
Length of hospitalization
Time Frame
From post-op day 1 to post-op day 3
Title
Changes between the 3 groups assessed by amount of days before return to oral intake status
Description
Return to oral intake status
Time Frame
From post-op day 1 to post-op day 3
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
undergoing epidural analgesia to treat perioperative pain associated with major surgery
undergoing major thoracic surgery
undergoing major abdominal surgery
undergoing major orthopaedic surgery
Exclusion Criteria:
sepsis
acute trauma
coagulopathy
preoperative hemodynamic instability
symptomatic coronary artery disease
patients from the ICU whose tracheas were intubated for any cause
allergies to medications in the protocol
primary or secondary block failure
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Olga C. Nin, MD
Organizational Affiliation
University of Florida
Official's Role
Principal Investigator
Facility Information:
Facility Name
UF Health
City
Gainesville
State/Province
Florida
ZIP/Postal Code
32610
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
The Prevention of Hypotension After Epidural Analgesia After Major Surgery
We'll reach out to this number within 24 hrs